Center Laboratories, Inc. (4123)
TWSE
31.35
+0.25 (+0.80%)
Closed
Oct 8, 2026
Day's Range
30.9031.35
52 wk Range
29.3548.96
Financial Statements - 4123 - Center Laboratories, Inc.
Revenue
1.51B▼ 6.3%
Net Income
9.32B▲ 944.9%Net Margin 614.9%
EBITDA
-265.56M▼ 272.3%
Free Cash Flow
-181.05M▼ 177.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.51B | 1.61B | 1.39B | 767.72M | 500.10M | 717.04M |
| Cost of Goods | 894.93M | 868.91M | 775.91M | 361.45M | 240.44M | 366.74M |
| Gross Profit | 621.25M | 748.95M | 618.09M | 406.26M | 259.65M | 350.30M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -362.08M | 234.32M | 78.53M | 284.43M | -254.15M | -472.80M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 11.56B | -1.17B | -1.11B | -588.91M | 2.59B | 5.99B |
| Income Tax | 2.24B | -66.62M | -66.26M | -13.29M | 438.69M | 1.11B |
| Net Income | 9.32B | -1.10B | -1.04B | -575.62M | 2.15B | 4.88B |
| EPS Basic | 11.743914 | -1.475217 | -1.5 | 0.16 | 2.850394 | 6.123252 |
| EPS Diluted | 10.896218 | -1.475217 | -1.5 | 0.16 | 2.768694 | 5.925216 |
| Basic Shares Outstanding | 793.54M | 745.80M | 663.95M | 644.63M | 636.50M | 618.31M |
| Diluted Shares Outstanding | 793.54M | 745.80M | 663.95M | 644.63M | 636.50M | 618.31M |
| Ebit | 11.77B | -942.50M | -913.72M | -506.22M | 2.69B | 6.08B |
| Ebitda | -265.56M | 154.16M | -175.17M | 164.95M | 1.07B | 349.11M |
| Net Income Continuous Operations | 11.56B | -1.17B | -1.11B | -588.91M | 2.59B | 5.99B |
| Minority Interests | 0 | -275K | 52.22M | 677.83M | -340.77M | -1.09B |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
